|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
| We’re going down soon, to move to a new Data Center today. We’ll be up ASAP. Sorry. |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 11/07/14 Biolase, Inc 10-Q 9/30/14 66:8.7M ActiveDisclosure/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 557K
2: EX-31.1 Certification -- §302 - SOA'02 HTML 28K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 28K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 21K
5: EX-32.2 Certification -- §906 - SOA'02 HTML 21K
44: R1 Document and Entity Information HTML 41K
34: R2 Consolidated Balance Sheets HTML 120K
42: R3 Consolidated Balance Sheets (Parenthetical) HTML 44K
46: R4 Consolidated Statements Of Operations And HTML 93K
Comprehensive Loss
61: R5 Consolidated Statements Of Cash Flows HTML 122K
36: R6 Description of Business and Basis of Presentation HTML 35K
41: R7 Summary of Significant Accounting Policies HTML 32K
31: R8 Stock-Based Awards and Per Share Information HTML 247K
23: R9 Inventory HTML 41K
62: R10 Property, Plant, and Equipment HTML 59K
48: R11 Intangible Assets and Goodwill HTML 111K
47: R12 Accrued Liabilities and Deferred Revenue HTML 124K
52: R13 Lines Of Credit and Other Borrowings HTML 36K
53: R14 Commitments and Contingencies HTML 52K
51: R15 Segment Information HTML 58K
54: R16 Concentrations HTML 72K
43: R17 Income Taxes HTML 30K
45: R18 Subsequent Event HTML 24K
50: R19 Accounting Policies (Policies) HTML 69K
66: R20 Stock-Based Awards and Per Share Information HTML 249K
(Tables)
57: R21 Inventory (Tables) HTML 39K
38: R22 Property, Plant, and Equipment (Tables) HTML 57K
49: R23 Intangible Assets and Goodwill (Tables) HTML 105K
40: R24 Accrued Liabilities and Deferred Revenue (Tables) HTML 129K
18: R25 Segment Information (Tables) HTML 50K
58: R26 Concentrations (Tables) HTML 69K
63: R27 Description of Business and Basis of Presentation HTML 57K
- Additional Information (Detail)
27: R28 Stock-Based Awards and Per Share Information - HTML 113K
Additional Information (Detail)
26: R29 Classification of Compensation Expense Associated HTML 28K
with Share-Based Payments (Detail)
29: R30 Assumptions Used in Estimating Fair Value of Stock HTML 31K
Options Granted (Detail)
30: R31 Summary of Option Activity (Detail) HTML 76K
32: R32 Cash Proceeds Along with Fair Value Disclosures HTML 33K
Related to Grants, Exercises, and Vesting Options
(Detail)
16: R33 Summary of Warrant Activity (Detail) HTML 51K
55: R34 Components of Inventory (Detail) HTML 30K
37: R35 Inventory - Additional Information (Detail) HTML 23K
39: R36 Components of Property, Plant, and Equipment HTML 40K
(Detail)
21: R37 Property, Plant, and Equipment - Additional HTML 23K
Information (Detail)
65: R38 Intangible Assets and Goodwill - Additional HTML 23K
Information (Detail)
12: R39 Summary of Intangible Assets, Related Accumulated HTML 45K
Amortization and Goodwill (Detail)
33: R40 Components of Accrued Liabilities (Detail) HTML 44K
60: R41 Changes in Initial Product Warranty Accrual and HTML 36K
Expenses Under Initial and Extended Warranties
(Detail)
20: R42 Accrued Liabilities and Deferred Revenue - HTML 25K
Additional Information (Detail)
25: R43 Summary of Deferred Revenue (Detail) HTML 37K
28: R44 Lines of Credit and Other Borrowings - Additional HTML 85K
Information (Detail)
35: R45 Commitments and Contingencies - Additional HTML 41K
Information (Detail)
15: R46 Segment Information - Additional Information HTML 34K
(Detail)
22: R47 Summary of Net Revenue by Geographic Location HTML 25K
(Detail)
13: R48 Concentrations - Summary of Net Revenue from HTML 29K
Various Products (Detail)
59: R49 Concentrations - Additional Information (Detail) HTML 24K
19: R50 Income Taxes - Additional Information (Detail) HTML 40K
56: R51 Subsequent Event - Additional Information (Detail) HTML 37K
64: XML IDEA XML File -- Filing Summary XML 99K
14: EXCEL IDEA Workbook of Financial Reports XLSX 128K
24: EXCEL IDEA Workbook of Financial Reports (.xls) XLS 1.40M
6: EX-101.INS XBRL Instance -- biol-20140930 XML 1.83M
8: EX-101.CAL XBRL Calculations -- biol-20140930_cal XML 131K
9: EX-101.DEF XBRL Definitions -- biol-20140930_def XML 369K
10: EX-101.LAB XBRL Labels -- biol-20140930_lab XML 967K
11: EX-101.PRE XBRL Presentations -- biol-20140930_pre XML 683K
7: EX-101.SCH XBRL Schema -- biol-20140930 XSD 138K
17: ZIP XBRL Zipped Folder -- 0001564590-14-005289-xbrl Zip 125K
Exhibit 31.2
CERTIFICATION OF THE CHIEF FINANCIAL OFFICER
PURSUANT TO SECTION 302 OF
THE SARBANES-OXLEY ACT OF 2002
I, Frederick D. Furry, certify that:
|
1. |
I have reviewed this quarterly report on Form 10-Q for the period ended September 30, 2014 of BIOLASE, Inc.; |
|
2. |
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
|
3. |
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
|
4. |
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
|
a. |
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
|
b. |
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
|
c. |
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; |
|
d. |
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
|
5. |
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s Board of Directors (or persons performing the equivalent functions): |
|
a. |
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
|
b. |
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
|
Date: November 7, 2014 |
By: |
|
|
|
|
|
|
|
|
Chief Financial Officer |
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 11/7/14 | 8-K, SC 13D/A | ||
| For Period end: | 9/30/14 | CORRESP, UPLOAD | ||
| List all Filings | ||||